Choice Genetics is a global leader in swine genetics, operating on four continents to support pork producers seeking the highest in efficiency, performance and value. Choice Genetics is part of Groupe Grimaud, the second largest multi-species company in the world and is the result of the merger of Newsham Choice Genetics and Pen Ar Lan who joined the group in 2008 and 2011 respectively.

Choice Genetics has subsidiaries in France, Germany, Poland, the USA, Canada, Brazil, Vietnam and China and has distributors in many more countries.

Leading Innovation.

Choice Genetics employs value-driven innovations that emphasize unique phenotypic traits to increase the accuracy of Estimated Breeding Values, bringing to market superior breeding stock.

Delivering Value.

Choice Genetics’ dedication to a unique innovation platform drives genetic advancement in commercial pig Total Value at a rate faster than competitors.



We are dedicated to value-driven R&D. We invest in science and technology innovations, bringing to market a superior product. Our unique selection platform currently includes measurement for feed efficiency, individually and in family groups, whole genome selection, selection for disease tolerance, and indexes that maximize margin.

The addition of CT technology to its genetic evaluation platform, scanning males and females at heavy North American market weights, will allow Choice Genetics to drive advancement in commercial pig total value at a rate faster than competitors.